SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (10223)5/27/1999 5:13:00 PM
From: Bluegreen  Respond to of 17367
 
FWHCO, so now you are saying Neuprex will be in short supply?? Is that it? One question. Is Xoma too stupid to have adequate supplies available in case EARLY HALT OF HEMO. TRAUMA? How many barrels of Neuprex will you need for that indication? Will ambulances be required to stock it for trauma if approved? BTW, thank you very much for attending the meeting and doing an excellent job of reporting.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News